HLA-matched sibling bone marrow transplantation for β-thalassemia major - Wikidata - wikimedia - TriplyDB

HLA-matched sibling bone marrow transplantation for β-thalassemia major

HLA-matched sibling bone marrow transplantation for β-thalassemia major

http://www.wikidata.org/entity/Q24600037

about

Current and future alternative therapies for beta-thalassemia major Hematopoietic stem cell transplantation in thalassemia and sickle cell anemia Advances in unrelated and alternative donor hematopoietic cell transplantation for nonmalignant disorders A prospective international cooperative information technology platform built using open-source tools for improving the access to and safety of bone marrow transplantation in low- and middle-income countries.Application of the Multiplicative-Additive Model in the Bone Marrow Transplantation Survival Data Including Competing Risks.Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel.Challenges and opportunities for international cooperative studies in pediatric hematopoeitic cell transplantation: priorities of the Westhafen Intercontinental Group.Improved clinical outcomes of high risk β thalassemia major patients undergoing a HLA matched related allogeneic stem cell transplant with a treosulfan based conditioning regimen and peripheral blood stem cell grafts Pretransplant immunosuppression followed by reduced-toxicity conditioning and stem cell transplantation in high-risk thalassemia: a safe approach to disease control Hematopoietic stem cell transplantation for homozygous β-thalassemia and β-thalassemia/hemoglobin E patients from haploidentical donors.Influence of glutathione S-transferase gene polymorphisms on busulfan pharmacokinetics and outcome of hematopoietic stem-cell transplantation in thalassemia pediatric patients Gene Therapy of the β-Hemoglobinopathies by Lentiviral Transfer of the β(A(T87Q))-Globin Gene.Developments in the prevention of transfusion-associated graft-versus-host disease.Conditioning regimens in allo-SCT for thalassemia major.A complicated disease: what can be done to manage thalassemia major more effectively?Unrelated donor stem cell transplantation for transfusion-dependent thalassemia.Pulmonary hypertension associated with thalassemia syndromes.Cure for thalassemia major - from allogeneic hematopoietic stem cell transplantation to gene therapy.Allogeneic hematopoietic stem cell transplantation for nonmalignant hematologic disorders using chemotherapy-only cytoreductive regimens and T-cell-depleted grafts from human leukocyte antigen-matched or -mismatched donors Hemopoietic stem cell transplantation in thalassemia: a report from the European Society for Blood and Bone Marrow Transplantation Hemoglobinopathy Registry, 2000-2010.Hematopoietic stem cell transplantation from non-sibling matched family donors for patients with thalassemia major in Jordan.Successful matched sibling donor marrow transplantation following reduced intensity conditioning in children with hemoglobinopathies.Outcomes of thalassemia patients undergoing hematopoietic stem cell transplantation by using a standard myeloablative versus a novel reduced-toxicity conditioning regimen according to a new risk stratification The Start-Up of the first Hematopoietic Stem Cell Transplantation Center in the Iraqi Kurdistan: a Capacity-Building Cooperative Project by the Hiwa Cancer Hospital, Sulaymaniyah, and the Italian Agency for Development Cooperation: an Innovative App Combined cord blood and bone marrow transplantation from the same human leucocyte antigen-identical sibling donor for children with malignant and non-malignant diseases.HLA-matched sibling stem cell transplantation in children with β-thalassemia with anti-thymocyte globulin as part of the preparative regimen: the Greek experience.HLA-matched family hematopoetic stem cell transplantation in children with beta thalassemia major: the experience of the Turkish Pediatric Bone Marrow Transplantation Group.Unrelated Donor Transplantation in Children with Thalassemia Using Reduced Intensity Conditioning - the URTH Trial.Allogeneic/Matched Related Transplantation for β-Thalassemia and Sickle Cell Anemia.Normalized levels of red blood cells expressing phosphatidylserine, their microparticles, and activated platelets in young patients with β-thalassemia following bone marrow transplantation.Pharmacokinetics and Pharmacodynamics of Treosulfan in Patients With Thalassemia Major Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.Risk adopted allogeneic hematopoietic stem cell transplantation using a reduced intensity regimen for children with thalassemia major.Combined umbilical cord blood and bone marrow from HLA-identical sibling donors for hematopoietic stem cell transplantation in children with hemoglobinopathies.Deferiprone (GPO-L-ONE(®) ) monotherapy reduces iron overload in transfusion-dependent thalassemias: 1-year results from a multicenter prospective, single arm, open label, dose escalating phase III pediatric study (GPO-L-ONE; A001) from Thailand.Late effects after hematopoietic stem cell transplantation for β-thalassemia major: the French national experience.

P2860

Q26750906-A68B6564-F9FC-48D0-8AB3-A89223110349 Q26824116-98E38E14-0C8F-48B2-B954-7051E54ADC4B Q27022561-0AAFF109-8963-43DA-9770-8BA000EAEA41 Q30486870-4DE3A513-090D-4D9C-B61C-CEFFC8B96B5E Q30968313-7C8750FA-9859-4EA1-A54F-F4E027CD1D72 Q33558770-75341C58-E182-4B5E-B304-A8EB5B2774C1 Q34343785-ABD52919-8051-4B54-A90E-31125E1C08D2 Q34700498-7256EDE7-527D-425C-B37B-8358CA16AFD8 Q35600557-E6535245-FCC3-41E9-A44F-8D50A2D3119A Q35924098-F42A500F-92CA-4C96-89FB-BBF747C86338 Q36650481-C9270749-3478-4C38-B262-6005460D8FFE Q36654528-45EBED7E-772D-408C-AEBC-C9629B947A2F Q38021811-008196C2-93F8-4C4F-B480-27319ED8B86A Q38179977-A214B619-7DD2-4ACD-9324-AC16BBAFC396 Q38607875-A94D1A1A-E216-4EE6-B64E-298C7A903256 Q38783216-4877BD7E-1328-4F90-BAC5-F10F28220E98 Q38786355-225572B6-4EB9-447E-8364-AE6229A4559D Q39026510-8B5B227A-D770-429A-8402-CCDED058AD60 Q39313203-02870972-2001-4962-89C6-288D32EE2087 Q40122851-6F59E246-C3CD-4748-8CFC-49E6DC0B71BB Q40401388-BB0B8A6A-7025-42AA-8DB5-948A146D2004 Q41010661-0C690189-1953-47CB-890F-DDA15FA1FCF2 Q41201160-0A6B97E2-8259-4183-B739-BFEA825314D5 Q42119640-7CE50E32-7E32-448D-809F-261EAD79F1CB Q44664430-ED19A991-19E0-444E-8F68-FABB0EBA3D26 Q44780289-41F9E49E-6693-465C-A90A-89628FAE322E Q47209088-7A9D1F10-8C33-4F7A-9B43-72E2FAB10C97 Q47548575-21B88495-651E-4D34-A36D-48AB68CC55E8 Q47614537-6691A746-B839-42B1-8DF6-E51E65049B2F Q48023068-A9AC3C02-2869-4C2A-9625-C8C1F0A5BB77 Q48106141-F4DDA3ED-F2E0-427D-AE34-AF647BE5097E Q50105348-0BAC2BB5-8F66-4B1A-BC9E-0A75B6231AFB Q51737112-FF5DD4C0-22AC-4FFF-9830-D4760AD9AD4F Q53995645-01FB35AD-1940-43F6-AAC2-976A0C347B7E Q55638215-D896946D-D2CB-4230-87BE-5AD39B926F99

P2860

HLA-matched sibling bone marrow transplantation for β-thalassemia major

http://www.wikidata.org/entity/Q24600037

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

HLA-matched sibling bone marrow transplantation for β-thalassemia major

@ast

HLA-matched sibling bone marrow transplantation for β-thalassemia major

@en

HLA-matched sibling bone marrow transplantation for β-thalassemia major

@nl

type

label

HLA-matched sibling bone marrow transplantation for β-thalassemia major

@ast

HLA-matched sibling bone marrow transplantation for β-thalassemia major

@en

HLA-matched sibling bone marrow transplantation for β-thalassemia major

@nl

prefLabel

HLA-matched sibling bone marrow transplantation for β-thalassemia major

@ast

HLA-matched sibling bone marrow transplantation for β-thalassemia major

@en

HLA-matched sibling bone marrow transplantation for β-thalassemia major

@nl

P1433

Q24600037-5A5E0D80-82AD-4A8F-B4DD-60BF253A6B37

P1476

Q24600037-E8B79370-7A41-4D32-9D53-472D08604643

P2093

Q24600037-0E25E197-73DB-4979-BCD1-BC4FF4226BAE

Q24600037-1637D486-762A-4B31-A209-6C142E643607

Q24600037-3B9C201C-7FA1-4DEC-A148-8BB48AB5C3D7

Q24600037-4173ABAB-E57F-455D-A141-0EE212248A87

Q24600037-6E8C7877-46C9-4C10-84E9-B07A89D32BF2

Q24600037-7D193682-6E37-4A4C-B091-31EFA240974F

Q24600037-8F3FB918-0575-4B2A-BD32-015FDEC717F8

Q24600037-945ECB13-6EEF-41B8-927B-546336FC6CB7

Q24600037-B3223FBF-E9E9-44ED-9CA2-B0246A0343D7

Q24600037-B7326776-2E63-4987-BA82-7EEC770D1EF1

P2860

Q24600037-1241D6BF-1C20-42E5-BFB9-37205D9E4A08

Q24600037-12A6C9B3-684B-485E-912E-C028B1DA0FB8

Q24600037-1C9296D7-7951-4C88-8D07-0474043ECCD6

Q24600037-2EC78DBC-FC6D-4D8D-A2CC-FEC7FB7A2376

Q24600037-36735730-AD4A-4CEA-B709-7B0EF733F2B8

Q24600037-3D02358B-1A47-442E-8E9F-E86DADD2BCEC

Q24600037-4BB66406-B600-4B9D-BE3E-E7713590273A

Q24600037-5613217F-732B-44C0-A8AC-E6ECD1AB5E81

Q24600037-5B1BFE8C-7F1D-48E0-8103-1D0741040BD0

Q24600037-5BB04A8B-1E2D-4C27-B686-E65FA248952B

P304

Q24600037-67A6101F-90EE-4358-BD8D-BB1AE19EC57B

P31

Q24600037-3A369783-FCFA-4963-A1A2-B0389B25F1BA

P356

Q24600037-09D52E29-ECA8-4F09-9D2A-47F1E597ADA9

P407

Q24600037-B2C16008-9C96-4147-B2FC-607C349F09C5

P433

Q24600037-DC029643-3E91-438D-85C3-575F4AF2BA6E

P478

Q24600037-F36C9EAC-1429-424F-885F-C9EA5C343D9F

P50

Q24600037-B81F3818-2638-43B9-B203-ADFB6444AF54

P577

Q24600037-0ACD0B10-3F71-4DA5-8574-5458641E18D9

P5875

Q24600037-38BE028B-E1F5-40C3-942D-1105DB0C6CAF

P698

Q24600037-DDAD06DB-2AC6-4F23-B86E-6788BD8E6F1F

P921

Q24600037-2E4724D9-4594-40C7-992B-0D06AEF98AB3

Q24600037-31C5C3E4-FA79-4E44-89D3-07C72BC038DC

Q24600037-4A5F7C10-6691-4674-AF45-B660B3AE630D

P932

Q24600037-7443BB5F-FFF3-4481-8B8E-CF9ED9BC8D42

P356

BLOOD-2010-09-306829

P1433

P1476

HLA-matched sibling bone marrow transplantation for β-thalassemia major

@en

P2093

Ardeshir Ghavamzadeh

http://www.w3.org/2001/XMLSchema#string

Brent R Logan

http://www.w3.org/2001/XMLSchema#string

Chi-Kong Li

http://www.w3.org/2001/XMLSchema#string

Christopher N Bredeson

http://www.w3.org/2001/XMLSchema#string

Gregory A Hale

http://www.w3.org/2001/XMLSchema#string

John Horan

http://www.w3.org/2001/XMLSchema#string

Mammen Chandy

http://www.w3.org/2001/XMLSchema#string

Mark C Walters

http://www.w3.org/2001/XMLSchema#string

Mary Eapen

http://www.w3.org/2001/XMLSchema#string

Mitchell Sabloff

http://www.w3.org/2001/XMLSchema#string

P2860

Beta-thalassemia

A new stratification strategy that identifies a subset of class III patients with an adverse prognosis among children with beta thalassemia major undergoing a matched related allogeneic stem cell transplantation.

Pathophysiology and treatment of graft-versus-host disease.

A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia.

Survival and complications in thalassemia.

Clinical hemoglobinopathies: iron, lungs and new blood.

Bone marrow transplantation in patients with thalassemia.

Second bone marrow transplantation for patients with thalassemia: risks and benefits.

Novel pharmacokinetic behavior of intravenous busulfan in children with thalassemia undergoing hematopoietic stem cell transplantation: a prospective evaluation of pharmacokinetic and pharmacodynamic profile with therapeutic drug monitoring.

Unpredictability of intravenous busulfan pharmacokinetics in children undergoing hematopoietic stem cell transplantation for advanced beta thalassemia: limited toxicity with a dose-adjustment policy.

P304

1745-50

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2010-09-306829

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

117

http://www.w3.org/2001/XMLSchema#string

P50

Robert Peter Gale

P577

2011-02-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49646547

http://www.w3.org/2001/XMLSchema#string

P698

21119108

http://www.w3.org/2001/XMLSchema#string

P921

P932

3056598

http://www.w3.org/2001/XMLSchema#string